The association of the paraoxonase 1 Q192R polymorphism with coronary artery disease (CAD) and cardiometabolic risk factors in Iranian patients suspected of CAD

被引:2
|
作者
Darand, Mina [1 ]
Salehi-Abargouei, Amin [2 ,3 ,4 ]
Vahidi Mehrjardi, Mohammad Yahya [5 ]
Feizi, Awat [6 ]
Seyedhossaini, Seyed Mustafa [4 ]
Askari, Gholamreza [1 ]
机构
[1] Isfahan Univ Med Sci, Nutr & Food Secur Res Ctr, Sch Nutr & Food Sci, Dept Community Nutr, Esfahan, Iran
[2] Shahid Sadoughi Univ Med Sci, Nutr & Food Secur Res Ctr, Yazd, Iran
[3] Shahid Sadoughi Univ Med Sci, Sch Publ Hlth, Dept Nutr, Yazd, Iran
[4] Shahid Sadoughi Univ Med Sci, Noncommunicable Dis Res Inst, Yazd Cardiovasc Res Ctr, Yazd, Iran
[5] Shahid Sadoughi Univ Med Sci, Res Ctr Food Hyg & Safety, Sch Publ Hlth, Yazd, Iran
[6] Isfahan Univ Med Sci, Sch Hlth, Dept Biostat & Epidemiol, Esfahan, Iran
来源
关键词
PON1; Q192R polymorphism; rs662; lipid profile; coronary artery disease; LOW-DENSITY-LIPOPROTEIN; PON1; GENE; LIPID-METABOLISM; TURKISH PATIENTS; HYPERCHOLESTEROLEMIA; ATHEROSCLEROSIS; CHOLESTEROL; SEVERITY; ADULTS;
D O I
10.3389/fcvm.2022.1037940
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThe present study aimed to investigate the association of the paraoxonase 1 (PON1) Q192R polymorphism with coronary artery disease (CAD) and cardiometabolic risk factors in Iranian patients suspected of CAD. MethodsThis cross-sectional study was conducted on 428 patients undergoing angiography. The data related to demographic information and physical activity were collected by valid and reliable questionnaires. The PON-1 genotypes were detected by the polymerase chain reaction-restriction fragment length polymorphism (RFLP-PCR) technique. The Gensini and SYNTAX score, anthropometric measurements, and biochemical and clinical parameters were measured by standard protocols. Results and discussionFindings indicated that the odds of obesity was significantly higher in people with the RR genotype compared to the QQ genotype carriers (OR: 2.95 CI: 1.25-6.93, P = 0.014) and also odds of low high-density lipoprotein cholesterol (HDL-C) was marginally higher (OR: 2.31 CI: 0.97-5.49, P = 0.056). There was no significant association between other CAD risk factors with PON1 Q192R polymorphism (P > 0.05). Further analysis showed a significant interaction between sex and 192QR (P = 0.019) and 192 RR (P = 0.007) genotypes on body mass index (BMI). More specifically, the risk of obesity in men carrying the RR genotype was 3.38 times (OR: 3.38 CI: 1.08-10.58, P = 0.036). Also, a significant joint effect of the RR genotype and sex on HDL-C was seen (P = 0.003). The stratification based on sex showed that the risk of low HDL-C is significantly higher in women carrying the RR genotype (OR: 6.18 CI: 1.21-31.46, P = 0.028). A marginal sex-genotype interaction was also found in the risk of elevated alanine aminotransferase (ALT) (P = 0.057). In summary, the findings showed that the risk of obesity and low HDL-C was higher in people carrying the RR genotype. On the other hand, a Q192R polymorphism-sex interaction was observed on the risk of obesity, elevated ALT, and low HDL-C.
引用
收藏
页数:10
相关论文
共 50 条
  • [11] Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm
    Ito, T
    Yasue, H
    Yoshimura, M
    Nakamura, S
    Nakayama, M
    Shimasaki, Y
    Harada, E
    Mizuno, Y
    Kawano, H
    Ogawa, H
    HUMAN GENETICS, 2002, 110 (01) : 89 - 94
  • [12] Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm
    Teruhiko Ito
    Hirofumi Yasue
    Michihiro Yoshimura
    Shota Nakamura
    Masafumi Nakayama
    Yukio Shimasaki
    Eisaku Harada
    Yuji Mizuno
    Hiroaki Kawano
    Hisao Ogawa
    Human Genetics, 2002, 110 : 89 - 94
  • [13] Paraoxonase-1 Q192R polymorphism and risk of sporadic amyotrophic lateral sclerosis
    Slowik, A
    Tomik, B
    Partyka, D
    Turaj, W
    Pera, J
    Dziedzic, T
    Szermer, P
    Figlewicz, DA
    Szczudlik, A
    CLINICAL GENETICS, 2006, 69 (04) : 358 - 359
  • [14] Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk
    Baum, L
    Ng, HK
    Woo, KS
    Tomlinson, B
    Rainer, TH
    Chen, XY
    Cheung, WS
    Chan, DKY
    Thomas, GN
    Tong, CSW
    Wong, KS
    CLINICAL BIOCHEMISTRY, 2006, 39 (03) : 191 - 195
  • [15] Q192R paraoxonase1 polymorphism is a risk factor for cataract in Pakistani population
    Baig, Amena
    Zohaib, Muhammad
    Ata-ur-Rehman
    Zarina, Shamshad
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 29 (03) : 765 - 771
  • [16] Impact of Paraoxonase Polymorphism (Q192R) on Endothelial Function in Intact Coronary Circulation
    Tetsunobu Yamane
    Tetsuya Matsumoto
    Ichiro Nakae
    Hiroyuki Takashima
    Yasuhiro Tarutani
    Shinji Tamaki
    Minoru Horie
    Hypertension Research, 2006, 29 : 417 - 422
  • [17] Impact of Paraoxonase Polymorphism (Q192R) on Endothelial Function in Intact Coronary Circulation
    Yamane, Tetsunobu
    Matsumoto, Tetsuya
    Nakae, Ichiro
    Takashima, Hiroyuki
    Tarutan, Yasuhiro
    Tamaki, Shinji
    Horie, Minoru
    HYPERTENSION RESEARCH, 2006, 29 (06) : 417 - 422
  • [18] Coronary artery disease risk in Chinese type 2 diabetics: is there a role for paraxonase 1 gene (Q192R) polymorphism?
    Osei-Hyiaman, D
    Hou, LF
    Fan, MB
    Ren, ZY
    Zhang, ZM
    Kano, K
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (06) : 639 - 644
  • [19] The Association of the Cholesterol Efflux Capacity with the Paraoxonase 1 Q192R Genotype and the Paraoxonase Activity
    Oniki, Kentaro
    Ohura, Kayoko
    Endo, Megumi
    Akatwijuka, Daniel
    Matsumoto, Erika
    Nakamura, Teruya
    Ogata, Yasuhiro
    Yoshida, Minoru
    Harada-Shiba, Mariko
    Saruwatari, Junji
    Ogura, Masatsune
    Imai, Teruko
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (09) : 1263 - 1276
  • [20] Q192R polymorphism of the paraoxonase-1 gene as a risk factor for obesity in Portuguese women
    Veiga, Luisa
    Silva-Nunes, Jose
    Melao, Alice
    Oliveira, Ana
    Duarte, Leone
    Brito, Miguel
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (02) : 213 - 218